Search Within

Neil Mukund Iyengar

Formats
  1. Meeting Abstract (71)
  2. Journal Article (61)
  3. Editorial (8)
  4. Review (8)
  5. Correspondence (6)
  6. Book Section (3)
  7. Research Letter (1)
Groups
  1. Breast Medicine Service (158)
  2. Department of Medicine (158)
  3. Population Sciences Research Program (158)
  4. Solid Tumor Oncology Division (158)
  5. Survivorship Research (158)
  6. Epidemiology and Biostatistics (47)

More Groups

People
  1. Clifford Hudis (57)
  2. Dilip Giri (31)
  3. Ayca Gucalp (29)
  4. Chau Dang (25)
  5. Monica Morrow (24)
  6. Patrick Morris (24)

More People

Years
  1. 2025 (11)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (21)
  5. 2021 (13)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Cancer Research (16)
  3. Oncology (Norwalk) (10)
  4. Blood (7)
  5. Cancer (7)
  6. Cancer Prevention Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. American Association for Cancer Research (22)
  3. C M P Medica LLC * The Oncology Group (10)
  4. Elsevier Inc. (10)
  5. Oxford University Press (9)
  6. Wiley Blackwell (9)

More Publishers

Results (158)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Argolo, D.; Smyth, L.; Chen, M. F.; Hudis, C. A.; Dang, C. T.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Systemic correlates of white adipose tissue inflammation in early-stage breast cancer
    Journal Article

    Iyengar, N. M.; Zhou, X. K.; Gucalp, A.; Morris, P. G.; Howe, L. R.; Giri, D. D.; Morrow, M.; Wang, H.; Pollak, M.; Jones, L. W.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression
    Journal Article

    Gucalp, A.; Iyengar, N. M.; Hudis, C. A.; Dannenberg, A. J.
    Seminars in Oncology (2016)

    Fulltext@MSK | Save
  • Obesity and cancer - Opportunities to break the link
    Journal Article

    Argolo, D. F.; Hudis, C. A.; Iyengar, N. M.
    Current Breast Cancer Reports (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Noninvasive detection of inflammatory changes in white adipose tissue by label-free raman spectroscopy
    Journal Article

    Haka, A. S.; Sue, E.; Zhang, C.; Bhardwaj, P.; Sterling, J.; Carpenter, C.; Leonard, M.; Manzoor, M.; Walker, J.; Aleman, J. O.; more...
    Analytical Chemistry (2016)

    Fulltext@MSK | Save
  • Obesity and cancer: Concepts and challenges
    Journal Article

    Argolo, D. F.; Iyengar, N. M.; Hudis, C. A.
    Indian Journal of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Impact of white adipose tissue inflammation on survival in patients with squamous cell carcinoma of the oral tongue
    Meeting Abstract

    Iyengar, N.; Ghossein, R.; Kochhar, A.; Morris, L.; Zhou, X.; Morris, P.; Awad, M.; Fury, M.; Pfister, D.; Patel, S.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save